# Pyxant Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pyxant-labs

- Industry: Pharmaceuticals
- Headquarters: Colorado Springs, US
- Website: www.pyxant.com
- Total disclosed funding: $1.3M
- Latest round: Series D (May 6, 2006)
- Investors on record: 2

## About

Pyxant Labs Inc. is a specialized bioanalytical Contract Research Organization (CRO) that provides advanced spatial imaging solutions and bioanalytical services to support pharmaceutical and biotechnology companies in drug development.Founded in 2000 and headquartered in Colorado Springs, US, Pyxant Labs Inc. operates as a bioanalytical CRO providing services to drug developers. The company has raised a total of USD 0.35 mn through funding rounds including a recent Series D round led by Colorado Venture Management. The firm has completed 5 deals to date.Pyxant Labs specializes in bioanalytical services that include advanced analytical techniques like MALDI mass spectrometry imaging, spatial omics, and LC-MS. These services support clients in the pharmaceutical and biotechnology sectors, aiding them throughout the drug development lifecycle from discovery phases to regulatory approval. Their expertise encompasses large molecules, small molecules, RNAi therapeutics, and antibody-drug conjugates, serving a diverse clientele across North America, Europe, and other global markets.Pyxant Labs generates revenue primarily through service contracts with pharmaceutical and biotech companies, which engage them for bioanalytical testing and spatial analysis. Financial transactions are structured around specific services provided, often linked to project milestones or retainers. Their revenue is bolstered by offerings like quantitative mass spectrometry imaging and advanced bioanalytical testing, all while adhering to rigorous regulatory standards.Looking ahead, Pyxant Labs Inc. aims to broaden its market reach by expanding services into new geographic regions. The funding from the recent Series D round will support these expansion efforts. All VC investors have exited their stake in the company, the financial terms of which were not disclosed.

## Funding rounds

- Series D, May 6, 2006, $0.3M — Colorado Venture Management
- Series B, Nov 22, 2004, $0.6M — Colorado Venture Management, Murphree Venture Partners
- Series A, Jul 18, 2002, $0.4M — Colorado Venture Management

## Investors

- Colorado Venture Management (https://capitalatlas.ai/funds/colorado-venture-management) — Series A, Series B, Series D
- Murphree Venture Partners (https://capitalatlas.ai/funds/murphree-venture-partners) — Series B